Warren Buffett Makes Major Moves Involving Exxon Mobil Corporation And GlaxoSmithKline Plc

A version of this article first appeared on

WASHINGTON, DC — The latest SEC filing from Warren Buffett’s Berkshire Hathaway listing the company’s stock holdings at the end of the third quarter was released last week, and the Oracle of Omaha has made some significant changes to his portfolio.

Last quarter, Berkshire Hathaway held stock in 42 companies worth approximately $89 billion — and, as of the most recent quarter, that number grew by about 3.5%, to $92 billion, with 43 companies, including one major addition. In fact, Buffett left his total share count of 33 of those companies identical — but he made major moves with others.

1. Added a $3.5 billion position in ExxonMobil (NYSE: XOM.US)

Warren Buffett’s biggest move of the quarter came in the form of a $3.5 billion investment in this energy giant. Buffett has long been a fan of large companies with a strong competitive advantage, and this is no exception, as Buffett now holds about 1% of the world’s second largest company.

The SEC filing does not say why Buffett added a stake in ExxonMobil, but the discipline and focus it adheres to when it comes to returning capital to shareholders is almost unparalleled. Considering it delivered another solid quarter of results in its most recent earnings release, it should come as no surprise that Buffett would want to invest in this stellar company.

2. Unloaded 75% of the GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) position

While Buffett had a “small” $73 million stake in the British pharmaceutical company at the end of the second quarter, he unloaded almost all of his holdings in the beleaguered market laggard during the third quarter. Considering that GlaxoSmithKline has been under a wealth of scrutiny lately as a result of allegations of bribery in China, and the patent expiring on its top-selling drug Advair, it may come as no surprise Berkshire Hathaway sold its position. While Berkshire didn’t have a major position in GlaxoSmithKline, he likely wasn’t thrilled with all the headaches associated with owning the company.

Getting paid to wait

At least Glaxo pays investors while they wait. That's one great thing about dividend stocks. Another big advantage is that over the long term, the compounding effect of the quarterly payouts, as well as their growth, adds up faster than most investors imagine. With this in mind, our analysts sat down to identify the absolute best safe havens in the FTSE 100.

All five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have been declared by the Fool as "5 Shares You Can Retire On"!

Just click here for the exclusive report -- it's completely free.

> Patrick owns shares of Berkshire Hathaway and ExxonMobil. The Motley Fool has recommended shares in GlaxoSmithKline.